Thrombospondin-1 in Bladder Cancer: Its Role and Prognostic Significance
Author Information
Author(s): Ioachim E, Michael MC, Salmas M, Damala K, Tsanou E, Michael MM, Malamou-Mitsi V, Stavropoulos NE
Primary Institution: University Hospital of Ioannina, Greece
Hypothesis
What is the prognostic significance of thrombospondin-1 expression in bladder cancer and its correlation with other factors?
Conclusion
Thrombospondin-1 expression does not predict recurrence or progression in bladder cancer, but lower levels are associated with more aggressive tumors.
Supporting Evidence
- 43% of cases showed low TSP-1 expression in tumor cells.
- Increased TSP-1 expression was related to increased microvessel density.
- Stromal TSP-1 expression was inversely correlated with tumor stage and size.
- No significant correlation was found between TSP-1 expression and recurrence or progression.
Takeaway
This study looked at a protein called thrombospondin-1 in bladder cancer to see if it could help predict how aggressive the cancer is. They found that lower levels of this protein might mean the cancer is more aggressive.
Methodology
Immunohistochemical analysis of TSP-1 expression in 148 bladder cancer tissue samples.
Limitations
The study did not find significant correlations between TSP-1 expression and recurrence or progression, which may limit its prognostic utility.
Participant Demographics
119 males and 29 females, aged 27 to 89 years (mean 66.7 years).
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website